The number of Ebola Virus Disease (EVD) cases and fatalities continued to climb on 10 and 11 August 2014, according to the World Health Organization (WHO) today.
A total of 128 new cases of Ebola virus disease (laboratory-confirmed, probable, and suspect cases) as well as 56 deaths were reported from Guinea, Liberia, Nigeria, and Sierra Leone.
This brings the outbreak total to 1,975 cases and 1,069 deaths in the four countries.
In addition, the makers of the experimental Ebola serum, ZMapp, Mapp Biopharmaceuticals announced yesterday that supplies of the monoclonal antibody drug candidate “has been exhausted”:
“The available supply of ZMapp™ has been exhausted. We have complied with every request for ZMapp™ that had the necessary legal/regulatory authorization. It is the requestors’ decision whether they wish to make public their request, acquisition, or use of the experimental drug. Any decision to use ZMapp™ must be made by the patients’ medical team. Drug has been provided at no cost in all cases.”
ZMapp was given to at least five Ebola cases–the two Samaritan’s Purse missionaries, Miguel Pajares, a Spanish priest who contracted the virus in Liberia and later died in Madrid and two Liberian physicians. For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page